Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07722884Recruiting
Randomised trial of tadalafil in benign prostatic hyperplasia (BPH) (3 arms), sponsored by Ain Shams University. Primary endpoint: International Prostate Symptom Score at 12 weeks. Started Jul 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07722884.